tradingkey.logo
tradingkey.logo
Suchen

SI-BONE Inc

SIBN
Zur Watchlist hinzufügen
17.110USD
+0.310+1.85%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
758.82MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über SI-BONE Inc Unternehmen

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

SI-BONE Inc Informationen

BörsenkürzelSIBN
Name des UnternehmensSI-BONE Inc
IPO-datumOct 17, 2018
CEOFrancis (Laura A)
Anzahl der mitarbeiter349
WertpapierartOrdinary Share
GeschäftsjahresendeOct 17
Addresse471 El Camino Real, Suite 101
StadtSANTA CLARA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl95050
Telefon14082070700
Websitehttps://si-bone.com/
BörsenkürzelSIBN
IPO-datumOct 17, 2018
CEOFrancis (Laura A)

Führungskräfte von SI-BONE Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
172.06K
+1.79%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
87.64K
+8.42%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
58.24K
-8.01%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
35.10K
+31.22%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
35.00K
+31.31%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
20.11K
+54.47%
Ms. Laura A. Francis
Ms. Laura A. Francis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Michael A. Pisetsky
Mr. Michael A. Pisetsky
Secretary, Chief Business & Legal Affairs Officer
Secretary, Chief Business & Legal Affairs Officer
--
--
Mr. Anthony J. Recupero, Ph.D.
Mr. Anthony J. Recupero, Ph.D.
President - Commercial Operations
President - Commercial Operations
--
--
Mr. Timothy E. (Ted) Davis, Jr.
Mr. Timothy E. (Ted) Davis, Jr.
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
172.06K
+1.79%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
87.64K
+8.42%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
58.24K
-8.01%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
35.10K
+31.22%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
35.00K
+31.31%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
20.11K
+54.47%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von SI-BONE Inc?

Die fünf größten Anteilseigner von SI-BONE Inc sind: Mr. Gregory K. (Greg) Hinckley, CPA

Wie viele Institutionen halten Anteile an SI-BONE Inc (SIBN)?

Mit Stand vom 2026Q1 halten 367 Institutionen Anteile an SI-BONE Inc, mit einem Gesamtmarktwert von etwa 45.75M, was 103.63% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -2298649.00 gestiegen.